Researchers Find a New Way to Block Severe Allergic Reactions in Mice

Summary

When you experience an allergic reaction, cells in your immune system called mast cells are usually the culprits. These cells act like tiny biological alarms. When triggered by allergy antibodies known as IgE, mast cells release inflammatory chemicals in a process called degranulation, causing everything from itchy skin to severe anaphylaxis. For years, scientists have searched for better ways to stop this cellular alarm system from going off in the first place.

Recently, researchers discovered that a specific internal cellular pathway, known as the IRE1-XBP1 axis, plays a crucial role in firing up these mast cells. To test if they could stop allergic reactions by blocking this pathway, the scientists used two specific chemical inhibitors called MBSA and KIRA6. When they treated mouse mast cells grown in the lab with these chemicals, the cells stopped releasing their inflammatory contents in response to allergy antibodies. Testing other cellular stress pathways did not yield the same results, showing that this specific biological axis is a unique trigger.

To confirm their findings, the research team genetically reduced the levels of the XBP1 protein in the cells, which successfully lowered the allergic response. Furthermore, they tested the chemical inhibitors in live mice and found that the treatments significantly suppressed severe allergic reactions known as anaphylaxis. While these findings are promising, the researchers caution that the work is currently limited to early-stage laboratory and mouse models. Much more research is needed to establish whether this approach can be safely translated to human patients.

The story in numbers.

IRE1 inhibitors tested (MBSA and KIRA6)

2

Other UPR pathways tested showing no effect (PERK and ATF6)

2